Essential Hypertension
Hypertension is the largest single contributor to global mortality, with approximately 25% of the population suffering from increased blood pressure. Hypertension is also a great economical burden with around 10% economic spent on therapies. However, though there are currently a myriad of potential therapeutics available around only half of current patients respond to the traditionally available treatment. This can be attributed to the complex presentation of the illness, with a combination of epigentics and environments resulting in a non-specific cause of hypertension in over 90% patients. Though the risk factors arising from hypertension are widely known, such as stroke, kidney failure and hear disease, the underlying mechanism of the pathophysiology is still not fully understood. Increased sympathetic nerve activity is widely recognised as a contributor to the increased blood pressure, however the precise cause of this is not known. In animal models of hypertension and in ...